Dr. Ollar received his Bachelor of Science Degree in 1970 from Fairleigh Dickenson University, Rutherford, New Jersey, USA. He received his Master of Science Degree in 1984 at Glasgow University, Glasgow, Scotland, United Kingdom. He received his Doctor of Philosophy Degree in 1993 from the University of Surrey, Guildford, England, United Kingdom During the course of his 30 year professional career, his research interests have included such diverse areas as: Mycobacteriology and Molecular Mycobacteriology in TB and AIDS-related Non-Tuberculous Mycobacterial Pathogens, Cholera Neuraminidase, Amytrophic Lateral Sclerosis, and the application of molecular markers for early detection in Pancreatic Cancer. He had been the head of the Molecular Biology Unit and also the Director of the Molecular Biology Program/Dept of Surgery at St. Vincent’s Hospital of New York prior to its closure on the 30th of April 2010. He had lectured on “Infections of the Central Nervous System”. He has a faculty appointment as a Clinical Assistant Professor of Neurology at New York Medical College and is an internationally respected specialist in Mycobacteriology and Molecular Mycobacteriology serving on committees with the WHO and CDC on Tuberculosis related issues. He had served on the special Task Force Committee of the Pennsylvania Department of Health to create a report entitled, “Lyme Disease in Pennsylvania”. He has also been cited in the Marquis Publication’s WHO’s WHO in North America for 2012.
Dr. Ollar current research focus is on the problems of misdiagnosis commonly associated with Neuroborreliosis. His specific focus is upon the application of specific microRNAs biomarkers in the early detection of ALS, MS and Alzheimer’s Disease, Parkinson’s Disease, and the potential of these biomarkers to distinguish true forms of the aforementioned neurodegenerative diseases, from cases manifesting clinical symptoms mimicking those illnesses.